Bench to bedside: Immunotherapy

11:00 am-12:30 pm

Room: M1

Programme stream(s): Cancer discovery / underpinning research , Treatment
Programme session type(s): Parallel session

Chair: Sophie Papa, Kings College London
Speaker: Gary Middleton, University of Birmingham
Speaker: Kevin Litchfield, The Francis Crick Institute
Speaker: Nicholas Powell, Imperial College London

As we strive to bring the impact of immunotherapy to a widening population of patients the focus is on combination approaches to prime immune responses and unmask neo-epitopes for T cell priming. To do this successfully we must understand the underlying immune-biology of host cancer interactions.
This session will explore the challenges we currently face in:
•Rational combination therapies
•Defining populations at risk of treatment failure and at risk of significant immune related toxicity
•Evidence driven approaches to toxicity management

This session is for people interested in moving their understanding of immune therapy beyond the current efficacy data.